$CPTN
Cepton, Inc. Stock $cptn

$cptn Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149823323000059 Filed on August 09, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$3.833M	$2.787M	$2.559M
YoY Change	112.47%	8.91%	185.92%
Cost Of Revenue	$3.339M	$2.353M	$3.082M
YoY Change	78.08%	-23.65%	133.84%
Gross Profit	$494.0K	$434.0K	-$523.0K
YoY Change	-795.77%	-182.98%	23.64%
Gross Profit Margin	12.89%	15.57%	-20.44%
Selling, General & Admin	$6.136M	$6.185M	$7.189M
YoY Change	-8.72%	-13.97%	95.94%
% of Gross Profit	1242.11%	1425.12%
Research & Development	$6.706M	$9.365M	$8.386M
YoY Change	-18.49%	11.67%	37.25%
% of Gross Profit	1357.49%	2157.83%
Depreciation & Amortization	$200.0K	$100.0K	$79.00K
YoY Change	159.74%	26.58%
% of Gross Profit	40.49%	23.04%
Operating Expenses	$12.84M	$15.55M	$15.58M
YoY Change	-14.09%	-0.16%	59.27%
Operating Profit	-$12.35M	-$15.12M	-$16.10M
YoY Change	-17.79%	-6.1%	57.79%
Interest Expense	$790.0K	$920.0K	-$585.0K
YoY Change	-348.43%	-257.26%	-5950.0%
% of Operating Profit
Other Income/Expense, Net	$2.000K	$2.000K	$4.000K
YoY Change	-100.41%	-50.0%
Pretax Income	-$11.29M	-$14.19M	$855.0K
YoY Change	-35.11%	-1759.3%	-108.38%
Income Tax	$0.00	$0.00	-$12.00K
% Of Pretax Income			-1.4%
Net Earnings	-$11.29M	-$14.19M	$843.0K
YoY Change	-35.13%	-1783.27%	-108.26%
Net Earnings / Revenue	-294.65%	-509.15%	32.94%
Basic Earnings Per Share	-$0.71	-$0.09	$0.01
Diluted Earnings Per Share	-$0.71	-$0.09	$0.01
COMMON SHARES
Basic Shares Outstanding	158.2M shares	156.8M shares	154.1M shares
Diluted Shares Outstanding	15.83M shares	157.4M shares	161.8M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$61.20M	$69.60M	$31.04M
YoY Change	183.1%	124.24%	4210.83%
Cash & Equivalents	$43.90M	$32.60M	$4.538M
Short-Term Investments	$17.30M	$37.00M	$26.50M
Other Short-Term Assets	$2.400M	$3.400M	$339.0K
YoY Change	664.33%	902.95%	323.75%
Inventory	$3.911M	$4.188M	$2.990M
Prepaid Expenses
Receivables	$2.100M	$2.100M	$1.676M
Other Receivables	$0.00	$0.00	$865.0K
Total Short-Term Assets	$69.53M	$79.25M	$43.20M
YoY Change	125.32%	83.45%	5306.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.999M	$2.028M	$1.019M
YoY Change	137.98%	99.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.49M	$10.89M	$1.687M
YoY Change	822.25%	545.58%
Total Long-Term Assets	$13.77M	$14.84M	$2.706M
YoY Change	596.41%	448.52%	-98.43%
TOTAL ASSETS
Total Short-Term Assets	$69.53M	$79.25M	$43.20M
Total Long-Term Assets	$13.77M	$14.84M	$2.706M
Total Assets	$83.30M	$94.09M	$45.90M
YoY Change	153.69%	104.97%	-73.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.400M	$2.900M	$2.489M
YoY Change	-19.54%	16.51%	3455.71%
Accrued Expenses	$3.409M	$3.056M	$2.447M
YoY Change	0.29%	24.89%
Deferred Revenue	$48.00K	$83.00K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$6.589M	$7.695M	$6.005M
YoY Change	13.76%	28.14%	8064.51%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$9.311M
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$9.500M	$10.20M	$3.641M
YoY Change	81.33%	180.14%	-57.71%
Total Long-Term Liabilities	$9.500M	$10.20M	$12.95M
YoY Change	-34.97%	-21.25%	50.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.589M	$7.695M	$6.005M
Total Long-Term Liabilities	$9.500M	$10.20M	$12.95M
Total Liabilities	$16.04M	$17.89M	$18.96M
YoY Change	-21.38%	-5.65%	118.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$126.3M	-$115.0M	-$53.40M
YoY Change	78.37%	115.37%	578.41%
Common Stock	$0.00	$2.000K	$2.000K
YoY Change	-100.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$31.63M	-$22.69M	$26.95M
YoY Change
Total Liabilities & Shareholders Equity	$83.30M	$94.09M	$45.90M
YoY Change	153.69%	104.97%	-73.51%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$11.29M	-$14.19M	$843.0K
YoY Change	-35.13%	-1783.27%	-108.26%
Depreciation, Depletion And Amortization	$200.0K	$100.0K	$79.00K
YoY Change	159.74%	26.58%
Cash From Operating Activities	-$9.290M	-$10.81M	-$12.79M
YoY Change	-17.28%	-15.46%	40835.43%
INVESTING ACTIVITIES
Capital Expenditures	$100.0K	$630.0K	-$434.0K
YoY Change	-688.24%	-245.16%
Acquisitions
YoY Change
Other Investing Activities	$20.00M	$1.500M	-$6.228M
YoY Change	142.37%	-124.08%
Cash From Investing Activities	$19.89M	$870.0K	-$6.662M
YoY Change	141.53%	-113.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00K	-60.00K	-597.0K
YoY Change	-99.44%	-89.95%
NET CHANGE
Cash From Operating Activities	-9.290M	-10.81M	-12.79M
Cash From Investing Activities	19.89M	870.0K	-6.662M
Cash From Financing Activities	10.00K	-60.00K	-597.0K
Net Change In Cash	10.61M	-10.00M	-20.05M
YoY Change	-969.67%	-50.11%	64073.9%
FREE CASH FLOW
Cash From Operating Activities	-$9.290M	-$10.81M	-$12.79M
Capital Expenditures	$100.0K	$630.0K	-$434.0K
Free Cash Flow	-$9.390M	-$11.44M	-$12.35M
YoY Change	-16.27%	-7.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	gcac	Temporary Equity Optional Redemption Period To Repurchase TemporaryEquityOptionalRedemptionPeriodToRepurchase	P2Y
CY2022Q4	gcac	Temporary Equity Optional Redemption Net Income Requirement Period TemporaryEquityOptionalRedemptionNetIncomeRequirementPeriod	P5Y
CY2022Q4	gcac	Temporary Equity Optional Redemption Related Party Redemption Period TemporaryEquityOptionalRedemptionRelatedPartyRedemptionPeriod	P7Y
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7695000	usd
CY2023Q2	gcac	Warrant Liability WarrantLiability	310000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	184000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9696000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	17885000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	100000	shares
CY2023Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	100000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	158224189	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	158224189	shares
CY2023Q2	us-gaap	Revenues Revenues	2787000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2353000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	434000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9365000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6185000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	15550000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-15116000	usd
CY2023Q2	gcac	Gain Loss On Earnout Liabiity GainLossOnEarnoutLiabiity	-26000	usd
CY2023Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	36000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	917000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14187000	usd
CY2023Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-3000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-14190000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157379175	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157379175	shares
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14190000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-11000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14205000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1633000	usd
CY2023Q1	gcac	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2023Q1	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	98891000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2280000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17000	usd
CY2023Q1	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	20000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-14742000	usd
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	100000	shares
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	98891000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-10784000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2362000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	63000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11000	usd
CY2023Q2	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-4000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-14190000	usd
CY2023Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	100000	shares
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	98891000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-22685000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	21671491	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	99470000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-87533000	usd
CY2022Q1	gcac	Temporary Equity Shares Retroactive Application Of Exchange Ratio TemporaryEquitySharesRetroactiveApplicationOfExchangeRatio	31407080	shares
CY2022Q1	gcac	Temporary Equity Shares Conversion Of Convertible Securities TemporaryEquitySharesConversionOfConvertibleSecurities	53078571	shares
CY2022Q1	gcac	Temporary Equity Value Conversion Of Convertible Securities TemporaryEquityValueConversionOfConvertibleSecurities	99470000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	99472000	usd
CY2022Q1	gcac	Stock Issued During Period Value Reverse Recapitalization Net Of Transaction Costs StockIssuedDuringPeriodValueReverseRecapitalizationNetOfTransactionCosts	-33050000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	273000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1357000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11000	usd
CY2022Q1	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-4000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	41198000	usd
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22249000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	211000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	38000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2229000	usd
CY2022Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	226000	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-37000	usd
CY2022Q2	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-8000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	843000	usd
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28932000	usd
	us-gaap	Net Income Loss NetIncomeLoss	42042000	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	235000	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	147000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4654000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3586000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	773000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	642000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	373000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-800000	usd
	gcac	Increase Decrease In Earnout Liability IncreaseDecreaseInEarnoutLiability	-736000	usd
	gcac	Increase Decrease In Earnout Liability IncreaseDecreaseInEarnoutLiability	-72308000	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-130000	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-2684000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-750000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1123000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	791000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1176000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1216000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	466000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-1958000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	670000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-202000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1406000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	741000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-178000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	791000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-148000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-289000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-753000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	298000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21240000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32274000	usd
	gcac	Purchases Of Property And Equipment PurchasesOfPropertyAndEquipment	1186000	usd
	gcac	Purchases Of Property And Equipment PurchasesOfPropertyAndEquipment	567000	usd
	gcac	Purchases Of Shortterm Investments PurchasesOfShorttermInvestments	37806000	usd
	gcac	Purchases Of Shortterm Investments PurchasesOfShorttermInvestments	32368000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	5902000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	5200000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	2773000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33792000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24260000	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	99884000	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	45220000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	76107000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	28897000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-29200000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21200000	usd
CY2022Q1	gcac	Exchange Ratio ExchangeRatio	2.449
CY2022Q1	gcac	Capital Stock Shares Authorized CapitalStockSharesAuthorized	355000000	shares
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	9724000	usd
	gcac	Proceeds From Issuance Of Common Stock Options Net Of Repurchase ProceedsFromIssuanceOfCommonStockOptionsNetOfRepurchase	13000	usd
	gcac	Proceeds From Issuance Of Common Stock Options Net Of Repurchase ProceedsFromIssuanceOfCommonStockOptionsNetOfRepurchase	447000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	63000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	54614000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	57431000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	429000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-13000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	884000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34518000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3654000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34529000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4538000	usd
	us-gaap	Interest Paid Net InterestPaidNet	63000	usd
	us-gaap	Interest Paid Net InterestPaidNet	444000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	12000	usd
	gcac	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	0	usd
	gcac	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	267000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	120000	usd
	gcac	Vesting Of Early Exercises Of Stock Options VestingOfEarlyExercisesOfStockOptions	0	usd
	gcac	Vesting Of Early Exercises Of Stock Options VestingOfEarlyExercisesOfStockOptions	76000	usd
	gcac	Initial Classification Of Warrant Liability InitialClassificationOfWarrantLiability	11190000	usd
	gcac	Initial Classification Of Warrant Liability InitialClassificationOfWarrantLiability	1789000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32600000	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	37000000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. The Company maintains a substantial portion of its cash and cash equivalents and short-term investments in money market funds, commercial paper, corporate debt securities, U.S. treasury securities, and U.S. government agency securities. Management believes that the financial institutions that hold its </span></div>cash, cash equivalents, and short-term investments are financially sound and, accordingly, represent minimal credit risk. Deposits held with banks may exceed the amount of federal insurance limits provided on such deposits.
	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, inventory valuation and reserves, warranty reserves, valuation allowance for deferred tax assets, valuation of earnout and warrant liabilities, stock-based compensation, useful lives of property, plant and equipment, income tax uncertainties, and other loss contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates, and such differences could be material to the Company’s condensed consolidated financial condition and results of operations.
	gcac	Product Warranty Term ProductWarrantyTerm	P1Y
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Reclassifications</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated statements of convertible preferred stock and stockholders’ equity (deficit) included in this Report for the six months ended June 30, 2022 differ from our previously filed Quarterly Report on Form 10-Q for the six months ended June 30, 2022 by reflecting the immaterial error correction for the misclassification of $1.6 million from prepaid expenses and other current assets to additional paid-in capital for the Lincoln Park Capital Fund, LLC (“Lincoln Park” or “LPC”) commitment fee obligation as of June 30, 2022. The Company corrected the error in the condensed consolidated financial statements for the nine months ended September 30, 2022. The Company believes the correction of the error is immaterial to the previously issued condensed consolidated financial statements for prior periods.</span></div>
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q1	gcac	Common Stock Conversion CommonStockConversion	1	shares
CY2022Q1	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	5950000	shares
CY2022Q1	gcac	Purchase Price Per Share PurchasePricePerShare	10.00
CY2022Q1	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	59500000	usd
CY2022Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	15589540	shares
CY2021Q1	gcac	Warrant Non Transferable Or Assignable Period WarrantNonTransferableOrAssignablePeriod	P30D
CY2021Q1	gcac	Expire Term ExpireTerm	P5Y
	us-gaap	Operating Leases Income Statement Initial Direct Costs OperatingLeasesIncomeStatementInitialDirectCosts	31700000	usd
CY2022Q1	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	2600000	usd
	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	0	usd
CY2022Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	76100000	usd
CY2022Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	40700000	usd
CY2023Q2	us-gaap	Revenues Revenues	2787000	usd
CY2023Q2	gcac	Revenue Percent Of Total RevenuePercentOfTotal	1
CY2022Q2	us-gaap	Revenues Revenues	2559000	usd
CY2022Q2	gcac	Revenue Percent Of Total RevenuePercentOfTotal	1
	us-gaap	Revenues Revenues	4272000	usd
	gcac	Revenue Percent Of Total RevenuePercentOfTotal	1
	us-gaap	Revenues Revenues	4044000	usd
	gcac	Revenue Percent Of Total RevenuePercentOfTotal	1
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	500000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	500000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1502000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	37036000	usd
CY2023Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	38538000	usd
CY2023Q2	gcac	Warrant Liabilities Fair Value Disclosure WarrantLiabilitiesFairValueDisclosure	310000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	184000	usd
CY2023Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	494000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	10437000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3703000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	14140000	usd
CY2022Q4	gcac	Warrant Liabilities Fair Value Disclosure WarrantLiabilitiesFairValueDisclosure	440000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	920000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1360000	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2210000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1179000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1188000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1141000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	790000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	665000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	4188000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2985000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	300000	usd
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	1972000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2533000	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1186000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1376000	usd
CY2023Q2	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	0	usd
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	993000	usd
CY2023Q2	gcac	Payroll Taxes Receivable Current PayrollTaxesReceivableCurrent	0	usd
CY2022Q4	gcac	Payroll Taxes Receivable Current PayrollTaxesReceivableCurrent	865000	usd
CY2023Q2	us-gaap	Prepaid Rent PrepaidRent	169000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	505000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3327000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6272000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3132000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1851000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1104000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	869000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2028000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	982000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	100000	usd
	us-gaap	Depreciation Depreciation	200000	usd
	us-gaap	Depreciation Depreciation	100000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1477000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1300000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1012000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	375000	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	484000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	525000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	83000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	65000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3056000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2265000	usd
CY2022Q1	gcac	Warrant Liability Issued WarrantLiabilityIssued	96998	shares
CY2022Q1	gcac	Warrant Liabilities Exercise Price WarrantLiabilitiesExercisePrice	16.89
CY2022Q1	gcac	Warrant Liabilities Fair Value Disclosure WarrantLiabilitiesFairValueDisclosure	1300000	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	700000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1400000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1100000	usd
CY2022Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	22806009	shares
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	21671491	shares
CY2022Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	21671491	shares
CY2022Q1	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	96661482	usd
CY2022Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	21671491	shares
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	21671491	shares
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2023Q1	gcac	Temporary Equity Incremental Costs TemporaryEquityIncrementalCosts	1100000	usd
CY2023Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	101900000	usd
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	2.585
CY2022Q4	gcac	Temporary Equity Optional Redemption Repurchase Notification Period TemporaryEquityOptionalRedemptionRepurchaseNotificationPeriod	P30D
CY2022Q4	gcac	Preferred Stock Put Right Conversion Percentage PreferredStockPutRightConversionPercentage	1.10
CY2022Q4	gcac	Preferred Stock Fundamental Change Voting Power PreferredStockFundamentalChangeVotingPower	0.50
CY2022Q4	gcac	Preferred Stock Fundamental Change Agreements Exceeding Percent PreferredStockFundamentalChangeAgreementsExceedingPercent	0.10
CY2023Q2	gcac	Common Stock Number Of Votes CommonStockNumberOfVotes	1	vote
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2023Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	158224189	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	158224189	shares
CY2021Q4	gcac	Sale Of Stock Number Of Lowest Closing Common Stock Sales Price SaleOfStockNumberOfLowestClosingCommonStockSalesPrice	3	salesprice
CY2021Q4	gcac	Sale Of Stock Average Sales Price Consecutive Days SaleOfStockAverageSalesPriceConsecutiveDays	10	salespriceday
CY2022Q3	gcac	Business Combination Commitment Fee Obligation Period BusinessCombinationCommitmentFeeObligationPeriod	P180D
CY2022Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	8372143	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14261984	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.14
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6486000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	45000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.37
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	128923	shares
	gcac	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceExercisable	0.10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	514617	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.07
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13663444	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1454000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10877597	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.62
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1448000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13663444	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2023Q2	gcac	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Aggregate Instrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAggregateInstrinsicValue	1454000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.17
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
	gcac	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriodWeightedAverageGrantDateFairValue	2.67
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2365000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2239000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4654000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3586000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	41000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	50000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	92000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	103000	usd
	us-gaap	Share Based Goods And Nonemployee Services Transaction Modification Of Terms Incremental Compensation Cost ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost	300000	usd
CY2023Q2	us-gaap	Share Price SharePrice	0.49
CY2022Q1	us-gaap	Share Price SharePrice	1.27
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.060
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.790
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0510
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0442
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y7M6D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y1M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	gcac	Earnout Liability Period Of Contingency EarnoutLiabilityPeriodOfContingency	P3Y
	gcac	Earnout Liability Period Of Contingency EarnoutLiabilityPeriodOfContingency	P3Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	200000	usd
	gcac	Gain Loss On Earnout Liability GainLossOnEarnoutLiability	700000	usd
CY2022Q2	gcac	Gain Loss On Earnout Liability GainLossOnEarnoutLiability	15600000	usd
	gcac	Gain Loss On Earnout Liability GainLossOnEarnoutLiability	72300000	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
	gcac	Warrants Redemption Notice WarrantsRedemptionNotice	P30D
	gcac	Warrants Trading Days Threshold WarrantsTradingDaysThreshold	20	tradingday
	gcac	Warrants Consecutive Trading Days Threshold WarrantsConsecutiveTradingDaysThreshold	30	tradingday
	gcac	Warrant Non Transferable Or Assignable Period WarrantNonTransferableOrAssignablePeriod	P30D
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	300000	usd
CY2022Q2	gcac	Excess Value Of Underwriter Warrants ExcessValueOfUnderwriterWarrants	1900000	usd
	gcac	Excess Value Of Underwriter Warrants ExcessValueOfUnderwriterWarrants	2000000	usd
CY2019Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	60000	shares
CY2019Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	100000	usd
CY2022Q1	gcac	Warrant Liability Issued WarrantLiabilityIssued	96998	shares
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-700000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y
	us-gaap	Operating Lease Cost OperatingLeaseCost	1468000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	743000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	408000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	420000	usd
	us-gaap	Lease Cost LeaseCost	1876000	usd
	us-gaap	Lease Cost LeaseCost	1163000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	984000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	888000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11190000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1789000	usd
CY2023Q2	gcac	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	0	usd
CY2022Q4	gcac	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	121000	usd
CY2023Q2	gcac	Operating Lease Right Of Use Asset Noncurrent OperatingLeaseRightOfUseAssetNoncurrent	10862000	usd
CY2022Q4	gcac	Operating Lease Right Of Use Asset Noncurrent OperatingLeaseRightOfUseAssetNoncurrent	324000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10862000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	445000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1697000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	211000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9696000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	281000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	11393000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	492000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M3D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y21D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1448
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1378
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1580000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3250000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3328000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3324000	usd
CY2023Q2	gcac	Lessee Operating Lease Liability To Be Paid After Year Three LesseeOperatingLeaseLiabilityToBePaidAfterYearThree	4215000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	15697000	usd
	us-gaap	Present Value Of Future Insurance Profit Experience Adjustment PresentValueOfFutureInsuranceProfitExperienceAdjustment	4304000	usd
	gcac	Net Lease Liabilities NetLeaseLiabilities	11393000	usd
CY2023Q2	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1200000	usd
CY2022Q2	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1300000	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2100000	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1800000	usd
CY2023Q2	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	800000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	1000000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	135160187	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	10027040	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145187227	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	16748	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	23465	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7600258	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56019340	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4067107	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment

Files In Submission

Name	View Source	Status
0001498233-23-000059-index-headers.html	Edgar Link	pending
0001498233-23-000059-index.html	Edgar Link	pending
0001498233-23-000059.txt	Edgar Link	pending
0001498233-23-000059-xbrl.zip	Edgar Link	pending
cptn-20230630xex311junpei.htm	Edgar Link	pending
cptn-20230630xex312hullxu.htm	Edgar Link	pending
cptn-20230630xex321junpei.htm	Edgar Link	pending
cptn-20230630xex322hullxu.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gcac-20230630.htm	Edgar Link	pending
gcac-20230630.xsd	Edgar Link	pending
gcac-20230630_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gcac-20230630_cal.xml	Edgar Link	unprocessable
gcac-20230630_def.xml	Edgar Link	unprocessable
gcac-20230630_lab.xml	Edgar Link	unprocessable
gcac-20230630_pre.xml	Edgar Link	unprocessable
gcac-20230630_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPTN
Cepton, Inc. Stock $cptn

2023 Q3 Form 10-Q Financial Statement

#000149823323000059 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPTN Cepton, Inc. Stock $cptn

2023 Q3 Form 10-Q Financial Statement

#000149823323000059 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPTN
Cepton, Inc. Stock $cptn